To streamline global operations, enhance productivity and position itself for growth, Eli Lilly and Co. recently revealed various personnel and structural adjustments to better align the Indianapolis-based pharmaceutical firm with desired outcomes.
Two executive leaders from Eagle Pharmaceuticals Inc., a specialist in enhancing injectable medication products, will present at 11 a.m. Wednesday at the 35th annual J.P. Morgan Healthcare Conference in San Francisco.
Accentuating widespread acceptance of the need to base U.S. health care on a strong, patient-centered primary care model, the American Association of Family Physicians recently released a paper proposing an advanced alternative payment model including comprehensive details.
Freelance health editor and blogger Barbara Fedoroff was recently named by the American Health Council to join its Industry Board to share her broad background in writing, legislative advocacy, phenomenology, interfaith ministry and more.
The national opioid addiction epidemic has caused many physicians to shy away from prescribing opioid pain pills to their patients and driven some to consider using genetic testing to detect a gene that may predispose patients to opioid addiction.
According to a recent article posted on The Hill’s website, a change needs to be made in regard to the 29 million people living in the United States with diabetes without knowing they have the disease.
Novartis has released the first results from its phase 3 clinical trials assessing the safety and effectiveness of pegpleranib combined with Lucentis (ranibizumab) -- and the company is reporting top-line results.
After comparing two time periods a decade apart, researchers recently concluded that hearing loss in U.S. adults ages 20-69 has actually declined over time, despite shifting demographic numbers as the general population ages.